SignalXSignalX

ARQ Arq, Inc.

Q3 2025 10-Q
Filed: Nov 5, 2025Period ending Sep 30, 2025
Health Care
Miscellaneous Chemical ProductsSEC EDGAR
Arq, Inc. Overview

Arq, Inc. (ARQ) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • No new or changed risk factors disclosed compared to most recent 10-K
  • • Continued forward-looking statement risks related to changing intentions without notice
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$35M

Net Income

-$653,000

Operating Margin

-2.4%

Net Margin

-1.9%

ROE

-0.3%

Total Assets

$278M

Source: XBRL data from Arq, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Arq, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.